Stockscreener 앱 받기
0.648
4.47%
0.0277
시간 외 거래:
.65
0.002
+0.31%
전일 마감가:
$0.6203
열려 있는:
$0.6161
하루 거래량:
136.47K
Relative Volume:
0.79
시가총액:
$24.44M
수익:
$7.88M
순이익/손실:
$-69.20M
주가수익비율:
-0.3176
EPS:
-2.04
순현금흐름:
$-69.73M
1주 성능:
+3.68%
1개월 성능:
-4.37%
6개월 성능:
-53.71%
1년 성능:
-37.69%
1일 변동 폭
$0.6161
$0.66
1주일 범위
$0.545
$0.66
52주 변동 폭
$0.545
$1.56
볼트 바이오테라퓨틱스 Stock (BOLT) Company Profile
명칭
Bolt Biotherapeutics Inc
전화
650-665-9295
주소
900 CHESAPEAKE DRIVE, REDWOOD CITY
볼트 바이오테라퓨틱스 Stock (BOLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | 개시 | Guggenheim | Buy |
| 2021-03-02 | 개시 | Morgan Stanley | Overweight |
| 2021-03-02 | 개시 | SVB Leerink | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
볼트 바이오테라퓨틱스 주식(BOLT)의 최신 뉴스
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 14.2% in September - Defense World
Bolt Biotherapeutics stock hits 52-week low at $0.61 - Investing.com
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Significant Decrease in Short Interest - Defense World
Bolt Biotherapeutics stock hits 52-week low at $0.65 By Investing.com - Investing.com Australia
Bolt Biotherapeutics stock hits 52-week low at $0.65 - Investing.com
Bolt Biotherapeutics Announces Changes to its Board of Directors - ForexTV.com
Bolt Biotherapeutics reshuffles board, appoints new chair By Investing.com - Investing.com Canada
Bolt Biotherapeutics reshuffles board, appoints new director - Investing.com
Bolt Biotherapeutics Announces Board Reshuffle and New Appointment - TipRanks
Bolt Biotherapeutics Announces Changes to its Board of Directors - Yahoo Finance
Deadline on Sept. 3rd coming up in Lawsuit for Investors in shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) - openPR
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesBOLT - PR Newswire
BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the - EIN News
BOLT Investors Have the Opportunity to Lead Bolt - GlobeNewswire
BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
BOLT DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
BOLT DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLT - GlobeNewswire Inc.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - The Malaysian Reserve
BOLT Deadline: BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
BOLT Deadline: BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - Morningstar
BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - GlobeNewswire Inc.
BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - GlobeNewswire Inc.
BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
BOLT FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, - GlobeNewswire
BOLT FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLT - GlobeNewswire Inc.
Sept. 3rd Deadline ALERT: Investors Who Lost More Than $100,000 With Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shares Should Contact the Shareholders Foundation - Newswire
Bolt Biotherapeutics to Participate in Upcoming September Conferences - StockTitan
AI Stocks Boom Is at Risk. Why Broadcom Earnings Are Make or Break and 5 Other Things to Know Today. - Barron's
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - Marketscreener.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt - GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BOLT - GlobeNewswire Inc.
BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - Marketscreener.com
BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - Morningstar
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLT - ForexTV.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - Marketscreener.com
NASDAQ: BOLT Lawsuit Alert: Investors Who Lost Money With Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Should Contact the Shareholders Foundation - AccessWire
NASDAQ: BOLT Lawsuit Alert: Investors Who Lost Money With Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Should Contact the Shareholders Foundation - Newswire
BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz & Grossman, LLC Today! - AccessWire
Bolt Biotherapeutics (FRA:6LP) Enterprise Value : €-25.84 Mil (As of Aug. 19, 2024) - GuruFocus.com
Bolt Biotherapeutics (FRA:6LP) 9-Day RSI : 36.07 (As of Aug. 18, 2024) - GuruFocus.com
BOLT (Bolt Biotherapeutics) Market Cap : $26.46 Mil (As of Aug. 18, 2024) - GuruFocus.com
BOLT (Bolt Biotherapeutics) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Bolt Biotherapeutics (NASDAQ:BOLT) Rating Reiterated by HC Wainwright - Defense World
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bolt - GlobeNewswire
볼트 바이오테라퓨틱스 (BOLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
4.86%
자본화:
|
볼륨(24시간):